. 2020 Mar 26;9(3):1562–1566. doi: 10.4103/jfmpc.jfmpc_944_19

Table 3.

Patient factors affecting the incontinence rate after botulinum toxin injection in chronic anal fissure

Factor/Complication	Incontinence	Without Incontinence	P
Age (years)	40.57±9.49	38.26±10.81	>0.05
Female Sex	14 (15.6%)	-	0.091
Duration of Disease (months)	13±8.8	9.56±18.05	>0.05
Duration of Local treatment (weeks)	2.14±0.36	2.17±1.09	>0.05
ite of Fissure
Posterior	6 (7.7%)	72 (92.3%)	0.019^a
Anterior	4 (28.6%)	10 (71.4%)	0.009^b
Posterior and Anterior	4 (28.6%)	10 (71.4%)

^aComparison of posterior fissures and anterior fissures, and also posterior fissures and simultaneous posterior and anterior fissures. ^bCalculated for trend